BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Dutta S, Wang FQ, Wu HS, Mukherjee TJ, Fishman DA. The NF-κB pathway mediates lysophosphatidic acid (LPA)-induced VEGF signaling and cell invasion in epithelial ovarian cancer (EOC). Gynecol Oncol 2011;123:129-37. [PMID: 21782227 DOI: 10.1016/j.ygyno.2011.06.006] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 2.2] [Reference Citation Analysis]
Number Citing Articles
1 Harrington BS, Annunziata CM. NF-κB Signaling in Ovarian Cancer. Cancers (Basel) 2019;11:E1182. [PMID: 31443240 DOI: 10.3390/cancers11081182] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 10.3] [Reference Citation Analysis]
2 Willier S, Butt E, Grunewald TG. Lysophosphatidic acid (LPA) signalling in cell migration and cancer invasion: a focussed review and analysis of LPA receptor gene expression on the basis of more than 1700 cancer microarrays. Biol Cell 2013;105:317-33. [PMID: 23611148 DOI: 10.1111/boc.201300011] [Cited by in Crossref: 91] [Cited by in F6Publishing: 91] [Article Influence: 10.1] [Reference Citation Analysis]
3 Abu El-Asrar AM, Mohammad G, Nawaz MI, Siddiquei MM, Kangave D, Opdenakker G. Expression of lysophosphatidic acid, autotaxin and acylglycerol kinase as biomarkers in diabetic retinopathy. Acta Diabetol 2013;50:363-71. [PMID: 22864860 DOI: 10.1007/s00592-012-0422-1] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 2.8] [Reference Citation Analysis]
4 Hu F, Wu C, Li Y, Xu K, Wang W, Cao H, Tian X. AGGF1 is a novel anti-inflammatory factor associated with TNF-α-induced endothelial activation. Cellular Signalling 2013;25:1645-53. [DOI: 10.1016/j.cellsig.2013.04.007] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 3.0] [Reference Citation Analysis]
5 Liu H, Wang L, Wang X, Cao Z, Yang Q, Zhang K. S100A7 enhances invasion of human breast cancer MDA-MB-468 cells through activation of nuclear factor-κB signaling. World J Surg Oncol 2013;11:93. [PMID: 23618129 DOI: 10.1186/1477-7819-11-93] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
6 Jeong KJ, Cho KH, Panupinthu N, Kim H, Kang J, Park CG, Mills GB, Lee HY. EGFR mediates LPA-induced proteolytic enzyme expression and ovarian cancer invasion: inhibition by resveratrol. Mol Oncol. 2013;7:121-129. [PMID: 23127547 DOI: 10.1016/j.molonc.2012.10.001] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 2.4] [Reference Citation Analysis]
7 Shao Y, Nanayakkara G, Cheng J, Cueto R, Yang WY, Park JY, Wang H, Yang X. Lysophospholipids and Their Receptors Serve as Conditional DAMPs and DAMP Receptors in Tissue Oxidative and Inflammatory Injury. Antioxid Redox Signal 2018;28:973-86. [PMID: 28325059 DOI: 10.1089/ars.2017.7069] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 4.0] [Reference Citation Analysis]
8 Jesionowska A, Cecerska-Heryc E, Matoszka N, Dolegowska B. Lysophosphatidic acid signaling in ovarian cancer. J Recept Signal Transduct Res 2015;35:578-84. [PMID: 26393967 DOI: 10.3109/10799893.2015.1026444] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 3.1] [Reference Citation Analysis]
9 Cao L, Zhang Y, Fu Z, Dong L, Yang S, Meng W, Li Y, Zhang W, Zhang J, Zheng C, Zhu H, Fan L. Diagnostic value of plasma lysophosphatidic acid levels in ovarian cancer patients: A case-control study and updated meta-analysis. J Obstet Gynaecol Res 2015;41:1951-8. [PMID: 26472266 DOI: 10.1111/jog.12806] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
10 Metelli A, Salem M, Wallace CH, Wu BX, Li A, Li X, Li Z. Immunoregulatory functions and the therapeutic implications of GARP-TGF-β in inflammation and cancer. J Hematol Oncol 2018;11:24. [PMID: 29458436 DOI: 10.1186/s13045-018-0570-z] [Cited by in Crossref: 23] [Cited by in F6Publishing: 26] [Article Influence: 5.8] [Reference Citation Analysis]
11 Ramesh S, Govindarajulu M, Suppiramaniam V, Moore T, Dhanasekaran M. Autotaxin⁻Lysophosphatidic Acid Signaling in Alzheimer's Disease. Int J Mol Sci 2018;19:E1827. [PMID: 29933579 DOI: 10.3390/ijms19071827] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 5.8] [Reference Citation Analysis]
12 Zhang Z, Zhu X. Clinical Significance of Lysophosphatidic Acid Receptor-2 (LPA2) and Krüppel-Like Factor 5 (KLF5) Protein Expression Detected by Tissue Microarray in Gastric Adenocarcinoma.Med Sci Monit. 2019;25:4705-4715. [PMID: 31235682 DOI: 10.12659/MSM.916336] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
13 Yung YC, Stoddard NC, Mirendil H, Chun J. Lysophosphatidic Acid signaling in the nervous system. Neuron 2015;85:669-82. [PMID: 25695267 DOI: 10.1016/j.neuron.2015.01.009] [Cited by in Crossref: 146] [Cited by in F6Publishing: 136] [Article Influence: 20.9] [Reference Citation Analysis]
14 Su Y, Gao L, Teng L, Wang Y, Cui J, Peng S, Fu S. Id1 enhances human ovarian cancer endothelial progenitor cell angiogenesis via PI3K/Akt and NF-κB/MMP-2 signaling pathways. J Transl Med 2013;11:132. [PMID: 23714001 DOI: 10.1186/1479-5876-11-132] [Cited by in Crossref: 33] [Cited by in F6Publishing: 26] [Article Influence: 3.7] [Reference Citation Analysis]
15 Abu El-Asrar AM, Nawaz MI, Mohammad G, Siddiquei MM, Alam K, Mousa A, Opdenakker G. Expression of bioactive lysophospholipids and processing enzymes in the vitreous from patients with proliferative diabetic retinopathy. Lipids Health Dis 2014;13:187. [PMID: 25496321 DOI: 10.1186/1476-511X-13-187] [Cited by in Crossref: 15] [Cited by in F6Publishing: 6] [Article Influence: 1.9] [Reference Citation Analysis]
16 Kim KH, Park SH, Do KH, Kim J, Choi KU, Moon Y. NSAID-activated gene 1 mediates pro-inflammatory signaling activation and paclitaxel chemoresistance in type I human epithelial ovarian cancer stem-like cells. Oncotarget 2016;7:72148-66. [PMID: 27708225 DOI: 10.18632/oncotarget.12355] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
17 Masoumi Moghaddam S, Amini A, Morris DL, Pourgholami MH. Significance of vascular endothelial growth factor in growth and peritoneal dissemination of ovarian cancer. Cancer Metastasis Rev 2012;31:143-62. [PMID: 22101807 DOI: 10.1007/s10555-011-9337-5] [Cited by in Crossref: 110] [Cited by in F6Publishing: 98] [Article Influence: 11.0] [Reference Citation Analysis]
18 Brooks D, Zimmer A, Wakefield L, Lyle LT, Difilippantonio S, Tucci FC, Illiano S, Annunziata CM, Steeg PS. Limited fibrosis accompanies triple-negative breast cancer metastasis in multiple model systems and is not a preventive target. Oncotarget 2018;9:23462-81. [PMID: 29805748 DOI: 10.18632/oncotarget.25231] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
19 Jia C, Li X, Sun H, Sui L. Over-expression of the overexpressed in lung cancer 1 is associated with poor prognosis in epithelial ovarian cancer. J Surg Oncol 2013;107:847-52. [PMID: 23609236 DOI: 10.1002/jso.23336] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
20 Li YL, Zhao H, Ren XB. Relationship of VEGF/VEGFR with immune and cancer cells: staggering or forward? Cancer Biol Med. 2016;13:206-214. [PMID: 27458528 DOI: 10.20892/j.issn.2095-3941.2015.0070] [Cited by in Crossref: 86] [Cited by in F6Publishing: 81] [Article Influence: 14.3] [Reference Citation Analysis]
21 Zeligs KP, Neuman MK, Annunziata CM. Molecular Pathways: The Balance between Cancer and the Immune System Challenges the Therapeutic Specificity of Targeting Nuclear Factor-κB Signaling for Cancer Treatment. Clin Cancer Res 2016;22:4302-8. [PMID: 27422962 DOI: 10.1158/1078-0432.CCR-15-1374] [Cited by in Crossref: 57] [Cited by in F6Publishing: 32] [Article Influence: 9.5] [Reference Citation Analysis]
22 Cristina de Oliveira-lima K, Farsky SHP, Lopes PH, de Andrade RMG, van den Berg CW, Tambourgi DV. Microcirculation abnormalities provoked by Loxosceles spiders' envenomation. Toxicon 2016;116:35-42. [DOI: 10.1016/j.toxicon.2015.08.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
23 Yang F, Wang H, Jiang Z, Hu A, Chu L, Sun Y, Han J. MicroRNA-19a mediates gastric carcinoma cell proliferation through the activation of nuclear factor-κB. Mol Med Rep 2015;12:5780-6. [PMID: 26239140 DOI: 10.3892/mmr.2015.4151] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
24 Afshari A, Uhde-Stone C, Lu B. Live visualization and quantification of pathway signaling with dual fluorescent and bioluminescent reporters. Biochem Biophys Res Commun 2014;448:281-6. [PMID: 24792187 DOI: 10.1016/j.bbrc.2014.04.108] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
25 Zhang J, Zhu J, Zhou Z, Chen W, Chen N. Therapeutic Effects of Ethyl Pyruvate on Tumor Growth and Metastasis in a Severe Combined Immunodeficiency Mouse Orthotopic Implantation Model. Eur J Inflamm 2012;10:25-32. [DOI: 10.1177/1721727x1201000103] [Cited by in Crossref: 5] [Article Influence: 0.5] [Reference Citation Analysis]
26 Yung YC, Stoddard NC, Chun J. LPA receptor signaling: pharmacology, physiology, and pathophysiology. J Lipid Res. 2014;55:1192-1214. [PMID: 24643338 DOI: 10.1194/jlr.r046458] [Cited by in Crossref: 359] [Cited by in F6Publishing: 209] [Article Influence: 44.9] [Reference Citation Analysis]